Northwire Canada EditionMonday, July 13, 2026
Northwire
S 0.160 +3.2% OMI 0.315 +0.0% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.280 +0.0% CAMB 0.990 −1.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.01 −1.9% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.390 −2.5% LIB 0.800 −12.1% SMY 0.290 +23.4% S 0.160 +3.2% OMI 0.315 +0.0% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.280 +0.0% CAMB 0.990 −1.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.01 −1.9% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.390 −2.5% LIB 0.800 −12.1% SMY 0.290 +23.4%
M&A / Property

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

VPT · Price

Executive Summary

  • VentriPoint Diagnostics announced a partnership with First Light Health to deliver AI‑powered cardiac diagnostics to Indigenous and remote communities across Canada, using its VMS+™ platform.
  • The company also disclosed recent commercial agreements: a deployment deal with LG Consulting Solutions for Northern California cardiac centres and a pilot model with the Nisga’a Valley Health Authority in northern BC.
  • These initiatives expand VentriPoint’s hub‑and‑spoke remote‑diagnostics model, positioning it to scale nationally and internationally, which is presented as a significant growth catalyst.

Key Details

  • Partnership Scope: First Light Health will act as the cultural‑safety and community liaison; local providers capture 2D echocardiograms that are transmitted to a central hub for specialist interpretation via VMS+™.
  • Geographic Coverage (Canada): British Columbia, Yukon, Alberta, Manitoba, New Brunswick – with plans to extend globally after validation.
  • Technology Claim: VMS+™ converts standard 2D echo images into 3D volumetric reconstructions “comparable to cardiac MRI” at a fraction of the cost and without MRI infrastructure.
  • Commercial Agreement (US): LG Consulting Solutions engaged to support VMS+™ rollout across Northern California, targeting cardiac centres in Sacramento and San Francisco regions.
  • Pilot Program: Earlier collaboration with Nisga’a Valley Health Authority piloted a similar hub‑and‑spoke model in northern BC.
  • Strategic Rationale: Aligns with broader industry shift toward outpatient/ambulatory care and AI adoption (70% of health orgs deploying AI per NVIDIA 2026 survey).
  • CEO Quote: “Our work with First Light Health… demonstrates the need for a made‑in‑Canada innovation that can close that gap. We see the potential for this solution to be widely deployed, from the Arctic to the Amazon.” – Hugh MacNaught, CEO, VentriPoint Diagnostics.

Notable Quotes

  • Hugh MacNaught (CEO, VentriPoint Diagnostics): “Cardiovascular disease doesn't respect geography, but too often, access to cardiac care does… This is what scalable, equitable heart care looks ….”

The release contains no financial statements, earnings data, financing terms, or M&A activity; the materiality assessment reflects a positive operational development.

Read the original news release →

More from VentriPoint Diagnostics Ltd.